EGFR and neoplasm: CTC counts correlated to tumor progression in patients with early lung adenocarcinoma and successfully detected typical mutant genes (Notch1, IGF2, EGFR, and PTCH1) [71,72] and genes in smokers as predictive biomarkers [73].